RET10Retatrutide 10 mg
Triple receptor agonist · GLP-1 / GIP / Glucagon · next-gen GLP
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2/3 trials show superior weight reduction versus dual agonists. 10 mg research vial.
For research use only. Not for human consumption.
Volume pricingper vial
| 1 vial | €49.90 |
| 10+ vials | — |
| 50+ vials | — |
| 100+ vials | — |
For laboratory research use only. Not for human or veterinary consumption.
COA / lab tests
View all →- Retatrutide 10 mg — ERP batchJanoshik
Order
Quantity (vials)
Tier price applies based on total vial count. For laboratory research use only.
